# Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

> **NCT05483010** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 16 (estimated)

## Conditions studied

- Clonal Cytopenia of Undetermined Significance
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT05483010
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-19
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483010, "Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05483010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*